Mira watched the telemetry. The drone climbed to 30 km, entered the stratosphere, and released a fine mist of nanoliposomes. The particles dispersed with the wind, descending slowly over the dunes.
On the monitor, a live feed displayed a digital read‑out of the viral RNA. The code was unlike anything Mira had seen. It used a —an extra base pair that the International Union of Pure and Applied Chemistry (IUPAC) had never catalogued. It seemed to be a synthetic amino acid encoded directly into the viral genome, a kind of RNA‑encoded protein that could be expressed without translation. nhdta 257 avi
Mira’s eyes widened. If they could synthesize protease P‑Δ and deliver it into any infected host, they could neutralize the virus. The problem was delivery : the protease needed to be packaged into a carrier that could cross cell membranes and reach the viral replication sites. Mira watched the telemetry
“I’ll need a sample,” she said.
Prologue The world had long since learned to trust the numbers on its medicine bottles more than the names on the labels. In the vaults beneath Geneva’s International Health Institute (IHI), a single, unassuming aluminum case sat on a steel shelf marked “NHDTA‑257 – AVi.” No one knew what the letters meant, and no one was allowed to ask. The case was sealed with a biometric lock, a tamper‑proof seal, and a single, blinking red light that pulsed like a slow, warning heartbeat. Chapter 1 – The Analyst Mira Patel had spent the last six years of her life in the sterile corridors of the IHI, sifting through terabytes of pathogen genomes, hunting for the next pandemic before it could find a host. She was a bio‑informatician, a quiet sort who could coax meaning out of a sea of nucleotides the way a composer coaxed melody from a single note. On the monitor, a live feed displayed a
Mira placed the cartridge on a sterile field and attached a micro‑pipette. The amber liquid was viscous, like honey caught in a glass sphere. She drew a microliter into a sterile vial, her gloved hands trembling.